In utero and lactational exposure to vinclozolin and genistein induces genomic changes in the rat mammary gland

Journal of Endocrinology

Volumn 216, Issue 2, 2013, Pages 245-263

  El Sheikh Saad, H ^a   Toullec, A ^a   Vacher, S ^b   Pocard, M ^a   Bieche, I ^b   Perrot Applanat, M ^a  

^a Université René Diderot   (France)

^b INSTITUT CURIE   (France)

Author keywords

Anti androgen vinclozolin; Ar; Endocrine disruptors; Genistein; Mammary gland development; Steroid receptors ER

Indexed keywords

BETA CASEIN; CLAUDIN 1; CYTOKERATIN 17; ESTROGEN RECEPTOR; GENISTEIN; STAT5A PROTEIN; VINCLOZOLIN; CLDN1 PROTEIN, RAT; ENDOCRINE DISRUPTOR; FUNGICIDE; OXAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DIETARY INTAKE; ESTRUS CYCLE; FEMALE; GENE EXPRESSION; GROWTH RETARDATION; HORMONE RESPONSE; IMMUNOCYTOCHEMISTRY; LIPID METABOLISM; MAMMARY GLAND; MORPHOGENESIS; MUSCLE DEVELOPMENT; NEWBORN; NEWBORN PERIOD; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PUBERTY; RAT; STEROIDOGENESIS; UPREGULATION; ANIMAL; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; LACTATION; METABOLISM; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL EXPOSURE; UDDER;

ANIMALS; CLAUDIN-1; ENDOCRINE DISRUPTORS; FEMALE; FUNGICIDES, INDUSTRIAL; GENISTEIN; IMMUNOHISTOCHEMISTRY; LACTATION; MAMMARY GLANDS, ANIMAL; OXAZOLES; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS;

MLCS; MLOWN;

EID: 84874771049     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0395     Document Type: Article

References (69)

1. Andersen HR, Vinggaard AM, Rasmussen TH, Gjermandsen IM & Bonefeld-Jorgensen EC. 2002 Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro. Toxicology and Applied Pharmacology 179 1-12.
2. Atwood CS, Hovey RC, Glover JP, Chepko G, Ginsburg E, Robison WG & Vonderhaar BK. 2000 Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice. Journal of Endocrinology 167 39-52.
3. Badger TM, Ronis MJ, Simmen RC & Simmen FA. 2005 Soy protein isolate and protection against cancer. Journal of the American College of Nutrition 24 146S-149S.
4. Bieche I, Tozlu S, Girault I & Lidereau R. 2004 Identification of a three-gene expression signature of poor-prognosis breast carcinoma. Molecular Cancer 3 37.
5. Brisken C & Rajaram RD. 2006 Alveolar and lactogenic differentiation. Journal of Mammary Gland Biology & Neoplasia 11 239-248.
6. Bursztyka J, Debrauwer L, Perdu E, Jouanin I, Jaeg JP & Cravedi JP. 2008 Biotransformation of vinclozolin in rat precision-cut liver slices: comparison with in vivo metabolic pattern. Journal of Agricultural and Food Chemistry 56 4832-4839.
7. Cameron HL & FosterWG2009 Developmental and lactational exposure to dieldrin alters mammary tumorigenesis in Her2/neu transgenic mice. PLoS ONE 4 e4303.
8. Christiansen S, Scholze M, Dalgaard M, Vinggaard AM, Axelstad M, Kortenkamp A & Hass U. 2009 Synergistic disruption of external male sex organ development by a mixture of four antiandrogens. Environmental Health Perspectives 117 1839-1846.
9. Daniel CW, Silberstein GB & Strickland P. 1987 Direct action of 17b-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Research 47 6052-6057.
10. Dimitrakakis C & Bondy C. 2009 Androgens and the breast. Breast Cancer Research 11 212.
11. Durando M, Kass L, Piva J, Sonnenschein C, Soto AM, Luque EH & Munoz-de-Toro M. 2007 Prenatal bisphenol A exposure induces preneoplastic lesions in themammary gland inWistar rats. Environmental Health Perspectives 115 80-86.
12. Durban EM, Medina D & Butel JS. 1985 Comparative analysis of casein synthesis during mammary cell differentiation in collagen and mammary gland development in vivo. Developmental Biology 109 288-298.
13. El Sheikh Saad H, Meduri G, Phrakonkham P, Berges R, Vacher S, Djallali M, Auger J, Canivenc-Lavier MC & Perrot-Applanat M. 2011 Abnormal peripubertal development of the rat mammary gland following exposure in utero and during lactation to a mixture of genistein and the food contaminant vinclozolin. Reproductive Toxicology 32 15-25.
14. Enoch RR, Stanko JP, Greiner SN, Youngblood GL, Rayner JL & Fenton SE. 2007 Mammary gland development as a sensitive end point after acute prenatal exposure to an atrazine metabolite mixture in female Long-Evans rats. Environmental Health Perspectives 115 541-547.
15. Eustache F, Mondon F, Canivenc-Lavier MC, Lesaffre C, Fulla Y, Berges R, Cravedi JP, Vaiman D & Auger J. 2009 Chronic dietary exposure to a low-dose mixture of genistein and vinclozolin modifies the reproductive axis, testis transcriptome, and fertility. Environmental Health Perspectives 117 1272-1279.
16. Fenton SE. 2006 Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. Endocrinology 147 S18-S24.
17. Foster WG, Younglai EV, Boutross-Tadross O, Hughes CL &WadeMG. 2004 Mammary gland morphology in Sprague-Dawley rats following treatment with an organochlorine mixture in utero and neonatal genistein. Toxicological Sciences 77 91-100.
18. Friedrichs N, Steiner S, Buettner R & Knoepfle G. 2007 Immunohistochemical expression patterns of AP2alpha and AP2gamma in the developing fetal human breast. Histopathology 51 814-823.
19. Gray LE Jr, Ostby JS & Kelce WR. 1994 Developmental effects of an environmental antiandrogen: the fungicide vinclozolin alters sex differentiation of the male rat. Toxicology and Applied Pharmacology 129 46-52.
20. Gray LE Jr, Ostby J, Monosson E & Kelce WR. 1999 Environmental antiandrogens: low doses of the fungicide vinclozolin alter sexual differentiation of the male rat. Toxicology and Industrial Health 15 48-64.
21. Gye MC. 2003 Expression of claudin-1 in mouse testis. Archives of Andrology 49 271-279.
22. Haslam SZ, Drolet A, Smith K, Tan M & Aupperlee M. 2008 Progestinregulated luminal cell and myoepithelial cell-specific responses in mammary organoid culture. Endocrinology 149 2098-2107.
23. Hilakivi-Clarke L, Cho E, Onojafe I, Raygada M & Clarke R. 1999a Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. Oncology Reports 6 1089-1095.
24. Hilakivi-Clarke L, Onojafe I, Raygada M, Cho E, Skaar T, Russo I & Clarke R. 1999b Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. British Journal of Cancer 80 1682-1688.
25. Hoover RN, Hyer M, Pfeiffer RM, Adam E, Bond B, Cheville AL, Colton T, Hartge P, Hatch EE, Herbst AL et al. 2011 Adverse health outcomes in women exposed in utero to diethylstilbestrol. New England Journal of Medicine 365 1304-1314.
26. Hvid H, Ekstrom CT, Vienberg S, Oleksiewicz MB & Klopfleisch R 2011 Identification of stable and oestrus cycle-independent housekeeping genes in the rat mammary gland and other tissues. Veterinary Journal 190 103-108.
27. Hvid H, Thorup I, Sjogren I, Oleksiewicz MB & Jensen HE 2012 Mammary gland proliferation in female rats: effects of the estrous cycle, pseudopregnancy and age. Experimental and Toxicologic Pathology 64 321-332.
28. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U & Speed TP 2003 Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 249-264.
29. Jager R, Schafer S, Hau-Liersch M & Schorle H 2010 Loss of transcription factor AP-2gamma/TFAP2C impairs branching morphogenesis of the murine mammary gland. Developmental Dynamics 239 1027-1033.
30. Jeschke J, Van Neste L, Glockner SC, Dhir M, Calmon MF, Deregowski V, Van Criekinge W, Vlassenbroeck I, Koch A, Chan TA et al. 2012 Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen. Epigenetics 7 701-709.
31. Kelce WR, Lambright CR, Gray LE Jr & Roberts KP 1997 Vinclozolin and p, p0-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism. Toxicology and Applied Pharmacology 142 192-200.
32. Korach KS, Couse JF, Curtis SW, Washburn TF, Lindzey J, Kimbro KS, Eddy EM, Migliaccio S, Snedeker SM, Lubahn DB et al. 1996 Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Progress in Hormone Research 51 159-186
33. Korde LA, Wu AH, Fears T, Nomura AM, West DW, Kolonel LN, Pike MC, Hoover RN & Ziegler RG 2009 Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiology, Biomarkers & Prevention 18 1050-1059.
34. Laier P, Metzdorff SB, Borch J, Hagen ML, Hass U, Christiansen S, Axelstad M, Kledal T, Dalgaard M, McKinnell C et al. 2006 Mechanisms of action underlying the antiandrogenic effects of the fungicide prochloraz. Toxicology and Applied Pharmacology 213 160-171.
35. Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R & Elgavish A 2002 Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. Journal of Nutrition 132 552S-558S.
36. Lehraiki A, Messiaen S, Berges R, Canivenc-Lavier MC, Auger J, Habert R & Levacher C 2011 Antagonistic effects of gestational dietary exposure to low-dose vinclozolin and genistein on rat fetal germ cell development. Reproductive Toxicology 31 424-430.
37. Lemaire G, Terouanne B, Mauvais P, Michel S & Rahmani R 2004 Effect of organochlorine pesticides on human androgen receptor activation in vitro. Toxicology and Applied Pharmacology 196 235-246.
38. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A & Hennighausen L 1997 Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes and Development 11 179-186.
39. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA Jr, Shyamala G, Conneely OM & O'Malley BW 1995 Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes and Development 9 2266-2278.
40. Markey CM, Luque EH, Munoz De Toro M, Sonnenschein C & Soto AM 2001 In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biology of Reproduction 65 1215-1223.
41. Mi H, Dong Q, Muruganujan A, Gaudet P, Lewis S & Thomas PD 2010 PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic Acids Research 38 D204-D210.
42. Molina-Molina JM, Hillenweck A, Jouanin I, Zalko D, Cravedi JP, Fernandez MF, Pillon A, Nicolas JC, Olea N & Balaguer P 2006 Steroid receptor profiling of vinclozolin and its primary metabolites. Toxicology and Applied Pharmacology 216 44-54.
43. Monosson E, Kelce WR, Lambright C, Ostby J & Gray LE Jr 1999 Peripubertal exposure to the antiandrogenic fungicide, vinclozolin, delays puberty, inhibits the development of androgen-dependent tissues, and alters androgen receptor function in the male rat. Toxicology and Industrial Health 15 65-79.
44. Moral R, Wang R, Russo IH, Mailo DA, Lamartiniere CA & Russo J 2007 The plasticizer butyl benzyl phthalate induces genomic changes in rat mammary gland after neonatal/prepubertal exposure. BMC Genomics 8 453.
45. Moral R, Wang R, Russo IH, Lamartiniere CA, Pereira J & Russo J 2008 Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature. Journal of Endocrinology 196 101-112.
46. Morris JS, Stein T, Pringle MA, Davies CR, Weber-Hall S, Ferrier RK, Bell AK, Heath VJ & Gusterson BA 2006 Involvement of axonal guidance proteins and their signaling partners in the developing mouse mammary gland. Journal of Cellular Physiology 206 16-24.
47. Moumen M, Chiche A, Cagnet S, Petit V, Raymond K, Faraldo MM, Deugnier MA & Glukhova MA 2011 The mammary myoepithelial cell. International Journal of Developmental Biology 55 763-771.
48. Munoz-de-Toro M, Markey CM, Wadia PR, Luque EH, Rubin BS, Sonnenschein C & Soto AM 2005 Perinatal exposure to bisphenol-A alters peripubertal mammary gland development inmice. Endocrinology 146 4138-4147.
49. Myal Y, Leygue E & Blanchard AA 2010 Claudin 1 in breast tumorigenesis: revelation of a possible novel "claudin high" subset of breast cancers. Journal of Biomedicine & Biotechnology 2010 956897. (doi:10.1155/2010/956897)
50. Nikolsky Y & Bryant J 2009 Protein networks and pathway analysis. Preface. Methods in Molecular Biology 563 v-vii.
51. Oakes SR, Naylor MJ, Asselin-Labat ML, Blazek KD, Gardiner-Garden M, Hilton HN, Kazlauskas M, Pritchard MA, Chodosh LA, Pfeffer OL et al. 2008 The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes and Development 22 581-586.
52. Pei RJ, Sato M, Yuri T, Danbara N, Nikaido Y & Tsubura A 2003 Effect of prenatal and prepubertal genistein exposure on N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats. In Vivo 17 349-357.
53. Peters AA, Buchanan G, Ricciardelli C, Bianco-Miotto T, Centenera MM, Harris JM, Jindal S, Segara D, Jia L, Moore NL et al. 2009 Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer. Cancer Research 69 6131-6140.
54. Peters AA, Ingman WV, Tilley WD & Butler LM 2011 Differential effects of exogenous androgen and an androgen receptor antagonist in the peri- and postpubertal murine mammary gland. Endocrinology 152 3728-3737. (doi:10.1210/en.2011-1133)
55. Raymond K, Cagnet S, Kreft M, Janssen H, Sonnenberg A & Glukhova MA 2011 Control of mammary myoepithelial cell contractile function by alpha3beta1 integrin signalling. EMBO Journal 30 1896-1906.
56. Robinson GW 2007 Cooperation of signalling pathways in embryonic mammary gland development. Nature Reviews. Genetics 8 963-972.
57. Russo IH & Russo J 1978 Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene. Journal of the National Cancer Institute 61 1439-1449.
58. Schedin P, Mitrenga T & Kaeck M 2000 Estrous cycle regulation of mammary epithelial cell proliferation, differentiation, and death in the Sprague-Dawley rat: a model for investigating the role of estrous cycling in mammary carcinogenesis. Journal of Mammary Gland Biology & Neoplasia 5 211-225.
59. Siegel PM & Muller WJ 2010 Transcription factor regulatory networks in mammary epithelial development and tumorigenesis. Oncogene 29 2753-2759.
60. Sohoni P & Sumpter JP 1998 Several environmental oestrogens are also anti-androgens. Journal of Endocrinology 158 327-339.
61. Somboonporn W & Davis SR 2004 Testosterone effects on the breast: implications for testosterone therapy for women. Endocrine Reviews 25 374-388.
62. Sternlicht MD, Kouros-Mehr H, Lu P & Werb Z 2006 Hormonal and local control of mammary branching morphogenesis. Differentiation 74 365-381.
63. Su Y, Shankar K, Rahal O & Simmen RC 2011 Bidirectional signaling of mammary epithelium and stroma: implications for breast cancer - preventive actions of dietary factors. Journal of Nutritional Biochemistry 22 605-611.
64. Vandenberg LN, Maffini MV, Wadia PR, Sonnenschein C, Rubin BS & Soto AM 2007 Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology 148 116-127.
65. Wang XJ, Bartolucci-Page E, Fenton SE & You L 2006 Altered mammary gland development in male rats exposed to genistein and methoxychlor. Toxicological Sciences 91 93-103.
66. Warri A, Saarinen NM, Makela S & Hilakivi-Clarke L 2008 The role of early life genistein exposures in modifying breast cancer risk. British Journal of Cancer 98 1485-1493.
67. Wu AH, Yu MC, Tseng CC & Pike MC 2008 Epidemiology of soy exposures and breast cancer risk. British Journal of Cancer 98 9-14.
68. Xie L, Law BK, Aakre ME, Edgerton M, Shyr Y, Bhowmick NA & Moses HL 2003 Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line. Breast Cancer Research 5 R187-R198.
69. Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor